AI-Enhanced App-based Intervention for Adolescent E-cigarette Cessation

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age14-20
SponsorState University of New York at Buffalo

About this trial

The goal of this quasi-experimental study is to test if a smartphone app can help adolescents aged 14-20 quit e-cigarettes. The main questions it aims to answer are:

* Can the app help adolescents manage cravings and increase their readiness to quit? * Does the personalized and real-time support provided by the app improve their success in quitting e-cigarettes?

Researchers will compare two groups: an immediate-intervention group that starts using the app right away and a delayed-intervention group that begins after three months, to see if the timing of app access influences outcomes in e-cigarette cessation.

Participants will:

* Set personal goals and track their daily progress within the app. * Use a real-time "urge" feature that provides immediate support during cravings. * Engage with a chatbot for quick answers and motivational support around quitting.

This study aims to create an accessible, personalized tool to help adolescents reduce or quit e-cigarette use, exploring its feasibility as a broader intervention model.

Eligibility criteria

Qualifiers

Adolescents who are 14 to 20 years old

Currently use nicotine-containing e-cigarettes (those responding "Yes" to: Have you used an electronic vaping product such as PuffBar, ElfBar, Lost Mary, JUUL, Vuse, e-cigarettes, vapes, vape pens, e-cigars, e-hookahs, hookah pens, or mods at least 1 day in the last 30 days? [CDC, 2020])

Interested in participating in an e-cigarette use cessation program

Owners of an iPhone or Android smartphone who use their phone daily

Disqualifiers

Individuals who fall outside the age range of 14 to 20 years

Those who have not used a nicotine-containing e-cigarette in the past 30 days

Individuals not interested in participating in an e-cigarette cessation program

Adolescents who do not own or regularly use an iPhone or Android smartphone

Trial design

Treatments tested in this trial

  • AI-enhanced smartphone app
  • AI-enhanced smartphone app, but with delayed access

Treatment groups

100 Participants
are divided into 2 treatment groups

Sponsors and collaborators

State University of New York at Buffalo

Lead sponsor

National Cancer Institute (NCI)

Collaborator

Advanced Bionics

Collaborator